Trial intelligence / Profile preview

Cannabidiol for Cocaine Addiction

NCT02559167Phase 2Completed

Sponsor
Centre hospitalier de l’Université de Montréal
Start
Jul 2016
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cannabidiol in cocaine dependence, sponsored by Centre hospitalier de l’Université de Montréal. Started Jul 2016; status: completed.

02

Drugs

cannabidiol
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT02559167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02559167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call